BioSpace News Archive

It was another busy week for clinical trial news ahead of the July 4 holiday in the U.S. Here’s a look.

On April 30th, SonoScape received the CE-marking, the product’s “Passport to Europe”, for its linear-array echoendoscope EG-UC5T. This further expands SonoScape’s endoscopic ultrasound (EUS) portfolio in the international market

Organogenesis Holdings Inc., a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, announced that second quarter of fiscal year 2021 financial results will be reported after the market closes on Monday, August 9th.

ProMIS Neurosciences, Inc., a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, announced the voting results of the Corporation’s annual meeting of shareholders held on June 30, 2021 in Vancouver, British Columbia, Canada.

Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional product candidates originally derived from proprietary algal cultures, today announced the closing of the sale of an additional 150,000 shares of common stock,

Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has acquired a majority stake in the reagent manufacturer CellGenix GmbH.

Tiziana Life Sciences plc, a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, announces that the Forms 20-F and F-6 filed by Accustem Sciences Limited with the SEC have been declared effective, enabling the completion of the in specie distribution and spin out of Accustem Sciences Limited.

Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced it will host a webcast and conference call to discuss results from the phase 1 study of MORF-057 following a presentation at the Congress of European Crohn’s and Colitis Organisation (ECCO) 2021 Virtual Congress.

The Pharmaceutical Industry Labor-Management Association today released an update to its first-of-its-kind report on the economic impact of the long-standing partnership between skilled craft unions and the biopharmaceutical industry in Illinois and 13 other states.

Transcenta Holding Limited (“Transcenta”), today announces that promising anti-tumor responses have been observed in the ongoing TST001 (anti-Claudin18.2 monoclonal antibody) trials.